Serologic testing of cornea donors

Cornea

Volumn 17, Issue 2, 1998, Pages 123-128

  Glasser, David B ^a,b  

^a Patuxent Medical Group   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cornea; Cytomegalovirus; Eye Bank Association of America; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Human T lymphotropic virus; Infection; Serology; Syphilis; Transplant

Indexed keywords

ARTICLE; CORNEA DISEASE; CORNEA TRANSPLANTATION; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; ORGAN DONOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY; TREPONEMA PALLIDUM;

EID: 0031882784     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199803000-00001     Document Type: Article

References (37)

1. Hoft RH, Pflugfelder SC, Forster RK, Ullman S, Polack FM, Schiff ER. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 1997;16:132-7.
2. Duffy P, Wolf J, Collins G, DeVoe AG, Streen B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-3.
3. Centers for Disease Control. Human-to-human transmission of rabies by a corneal transplant: Idaho. MMWR 1979;28:109-11.
4. Houff SA, Burton RC, Wilson RW, et al. Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979; 300:603-4.
5. Centers for Disease Control. Human-to-human transmission of rabies via a corneal transplant: France. MMWR 1980;29:25-6.
6. Centers for Disease Control. Human-to-human transmission of rabies via a corneal transplant: Thailand. MMWR 1981;30:473-5.
7. Gode GR, Bhide NK. Two rabies deaths after corneal grafts from one donor. Lancet 1988;2:791.
8. Javadi MA, Fayaz A, Mirdehghan SA, Ainollahi B. Transmission of rabies by corneal graft. Cornea 1996;15:431-3.
9. Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea 1995; 14:547-53.
10. Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet 1985;2:529-30.
11. Salahuddin SZ, Palestine AG, Heck E, et al. Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. Am J Ophthalmol 1986;101:149-52.
12. Heck E, Petty C, Palestine A, et al. ELISA HIV testing and viral culture in the screening of corneal tissue for transplant from medical examiner cases. Cornea 1989;8:77-80.
13. Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price RW. Confirmation of HTLV-III virus in cornea. Am J Ophthalmol 1986; 102:390-1.
14. Cantrill HL, Henry K, Jackson B, Erice A, Ussery FM, Balfour HH. Recovery of human immunodeficiency virus from ocular tissue in patients with acquired immune deficiency syndrome. Ophthalmology 1988;95:1458-62.
15. Qavi HB, Green MT, Segall GK, Hollinger FB, Lewis DE. The incidence of HIV-1 and HHV-6 in corneal buttons. Curr Eye Res 1991;10:97-103.
16. O'Day DM. Donor selection. In: Brightbill FS, ed. Corneal surgery: theory, technique, and tissue, 2nd ed. St. Louis: Mosby, 1993:549-55.
17. Pepose JS, MacRae S, Quinn TC, Ward JW. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am J Ophthalmol 1987;103:798-801.
18. Schwarz A, Hoffmann F, L'age-Stehr J, Tegzess AM, Offermann G. Human immunodeficiency virus transmission by organ donation: outcome in cornea and kidney recipients. Transplantation 1987;44:21-4.
19. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-88.
20. Sloand EM, Pitt E, Chiarello RJ, Nemo GJ. HIV testing: state of the art. JAMA 1991;266:2861-6.
21. Pepose JS, Pardo F, Kessler JA II, et al. Screening cornea donors for antibodies against human immunodeficiency virus: efficacy of ELISA testing of cadaveric sera and aqueous humor. Ophthalmology 1987;94:95-100.
22. Pepose JS, Holland GN, Buerger DG, MacRae SM. Changes in eye bank medical standards in response to the AIDS epidemic. In: Brightbill FS, ed. Corneal surgery: theory, technique, and tissue, 2nd ed. St. Louis: Mosby, 1993:590-6.
23. Essary LR, Kinard SJ, Butcher A, et al. Screening potential corneal donors for HIV-1 by polymerase chain reaction and a colorimetric microwell hybridization assay. Am J Ophthalmol 1996;122:526-34.
24. Mattern RM, Cavanagh HD. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant? Cornea 1997;16:138-45.
25. Laycock KA, Essary LR, Delaney S, Kuhns MC, Pepose JS. A critical evaluation of hepatitis C testing of cadaveric corneal donors. Cornea 1997;16:146-50.
26. Laycock KA, Wright TL, Pepose JS. Lack of evidence for hepatitis C virus in corneas of seropositive cadavers. Am J Ophthalmol 1994;117:401-2.
27. Pereira BJ, Milford EL, Kirkman RL, et al. Low risk of liver disease after tissue transplantation from donors with HCV. Lancet 1993;341:903-4.
28. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-8.
29. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988;240:643-6.
30. Goldberg MA, Laycock KA, Kinard S, Wang H, Pepose JS. Poor correlation between reactive syphilis serology and human immunodeficiency virus testing among potential cornea donors. Am J Ophthalmol 1995;119:1-6.
31. Macsai MS, Norris SJ. OptiSol corneal storage medium and transmission of Treponema pallidum. Cornea 1995;14:595-600.
32. Nankervis GA, Kumar ML. Diseases produced by cytomegalovirus. Med Clin North Am 1978;62:1021-35.
33. Holland EJ, Bennett SR, Brannian R, Osborne JC, Goeken JA, Krachmer JH. The risk of cytomegalovirus transmission by pen-etrating keratoplasty. Am J Ophthalmol 1988;105:357-60.
34. Pepose JS. The risk of cytomegalovirus transmission by penetrating keratoplasty. Am J Ophthalmol 1988;106:238-9.
35. Holland EJ, Bennett SR, Brannian R, Osborne JC, Goeken JA, Krachmer JH. The risk of cytomegalovirus transmission by penetrating keratoplasty [Letter]. Am J Ophthalmol 1988;106:239-40.
36. Feigenbaum S, Pepose JS. Screening corneal donors for transmissible disease: safety, resources, and reason. Arch Ophthalmol 1991;109:941-3.
37. Sugar J, Mannis M. Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough? Cornea 1997;16:123.